CHALESE HANNAN: Open Payments
NPI 1548923543 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 11 payments from 6 companies in 2025. Trend: 2023 $296 · 2024 $257 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $252 |
| Madrigal Pharmaceuticals | 2 | $164 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Averitas Pharma Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: REZDIFFRA, MAVYRET, VRAYLAR, Qelbree, QUTENZA, Cologuard Collection Kit, UZEDY.
Industry payments across OK — which companies pay providers there.
